Webinar

Understanding AMR : Revisiting Doxycycline Time to Rebuild its Reputation

19th April, 2021
05:30 PM

Overview

According to the World Health Organization (WHO), we are rapidly approaching a 'post-antibiotic' era. The knowledge gap about antibiotic resistance and room for progress is evident and unified combating strategies to mitigate the inadvertent trends of resistance seem to be lacking. Doxycycline remains a valuable antimicrobial agent by virtue of its potent microbiological profile, anti-inflammatory and immunomodulatory activity, and practical advantages like cost-effectiveness and ease of availability. Indian clinicians may like to consider doxycycline optimally for effective infection care. This may help Indian healthcare system, in defying the massive battle against anti-microbial resistance.

  Speakers

Dr. KK Aggarwal

Dr. KK Aggarwal

President Heart Care Foundation of India and Group Editor in Chief MEDtalks


Dr. Shyam Sundar

Dr. Shyam Sundar

Distinguished Professor, Infectious Diseases Research Laboratory, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi


Powered By

sponser
Understanding AMR : Revisiting Doxycycline Time to Rebuild its Reputation | Live Webinar | Medtalks
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Download Our App

Connect With Us